Hedge fundNew York13F filer since 2002

Glenview Capital

Managed by Larry Robbins, founder and CEO

13F portfolio value$5.0BQ2 2026 · up 36% vs Q1

Positions4212 new · 11 sold out

Top 10 weight64%of portfolio value

Turnover34%vs Q1

Largest holdingGPN12.9% of portfolio

Last filingAug 14for Q2 2026

What changed in Q2 2026

Automated summary of the 13F · filed Aug 14, 2026

Added to GPN (+40% shares) and THC (+47% shares); new positions in A, LLY and MKSI.

Biggest cut: AMD (−54% of shares). Sold out of DXC, GTM and USFD.

Since the quarter ended, the top 10 holdings on Markets are up about 15.5% on average, led by TMO and AMZN.

Holdings · Q2 2026

1GPNGlobal Pmts12.9%$646M8.9MAdded +40%——

2CVSCVS Health10.0%$499M4.8MTrimmed −41%——

3THCTenet Healthcare8.4%$418M2.2MAdded +47%——

4TMOThermo Fisher Scientific6.3%$314M627KAdded +150%+43.3%—

5AMZNAmazon.com, Inc.6.1%$303M1.3MAdded +20%+11.8%1.0%

6AAgilent Technologies5.2%$262M2.0MNew——

7DHRDanaher4.4%$218M1.1MAdded +633%——

8METAMeta Platforms4.0%$201M357KAdded +191%+11.7%1.2%

9AMDAdvanced Micro Devices3.5%$173M298KTrimmed −54%−4.8%2.4%

10Teva Pharmaceutical IndsTeva Pharmaceutical Inds3.4%$172M5.1MTrimmed −24%——

Sector allocation

Healthcare8%+5.1 ptConsumer discretionary6%+0.1 ptTechnology5%−1.2 ptCommunication4%+2.1 ptIndustrials3%−0.2 ptOther74%−5.8 pt

Change shown in percentage points vs Q1. Holdings outside Markets’ coverage count as Other.

Reported portfolio value

$4.7B

$4.0B

$3.5B

$4.1B

$4.7B

$3.7B

$5.0B

Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

13F market value at each quarter end, US long positions only.

Not investment advice. From SEC Form 13F filings (SEC EDGAR 13F). Following an investor alerts you when their next filing lands; it does not copy trades.